PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.15%
Revenue growth above 1.5x AVGO's 4.04%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.95%
Gross profit growth above 1.5x AVGO's 8.86%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
29.79%
EBIT growth 1.25-1.5x AVGO's 20.42%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
29.79%
Operating income growth 1.25-1.5x AVGO's 20.42%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
31.23%
Net income growth 1.25-1.5x AVGO's 24.28%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
30.51%
EPS growth 1.25-1.5x AVGO's 26.09%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
31.03%
Diluted EPS growth 1.25-1.5x AVGO's 27.27%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.32%
Slight or no buybacks while AVGO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.16%
Slight or no buyback while AVGO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.32%
Dividend reduction while AVGO stands at 13.29%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.34%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-11.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
463.61%
10Y revenue/share CAGR at 50-75% of AVGO's 713.93%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
275.12%
5Y revenue/share CAGR above 1.5x AVGO's 80.31%. David Dodd would look for consistent product or market expansions fueling outperformance.
72.26%
3Y revenue/share CAGR above 1.5x AVGO's 29.56%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
942.36%
10Y OCF/share CAGR at 50-75% of AVGO's 1391.36%. Martin Whitman might fear a structural deficiency in operational efficiency.
424.44%
5Y OCF/share CAGR above 1.5x AVGO's 149.52%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
26.56%
3Y OCF/share CAGR under 50% of AVGO's 59.14%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
1254.35%
Net income/share CAGR 1.25-1.5x AVGO's 1076.00%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
743.56%
5Y net income/share CAGR at 75-90% of AVGO's 901.67%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
49.99%
Below 50% of AVGO's 410.83%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
421.55%
10Y equity/share CAGR at 50-75% of AVGO's 570.28%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
286.90%
5Y equity/share CAGR above 1.5x AVGO's 17.00%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
137.40%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
38.08%
Below 50% of AVGO's 296.37%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
6.16%
Below 50% of AVGO's 60.91%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
24.50%
AR growth well above AVGO's 22.60%. Michael Burry fears inflated revenue or higher default risk in the near future.
9.09%
Inventory growth well above AVGO's 17.19%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.96%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
10.78%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
1.86%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.52%
R&D growth drastically higher vs. AVGO's 0.50%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.38%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.